BTG plc’s “Buy” Rating Reaffirmed at Deutsche Bank (BTG)
BTG plc (LON:BTG)‘s stock had its “buy” rating reaffirmed by research analysts at Deutsche Bank in a report released on Wednesday. They currently have a GBX 655 ($11.16) target price on the stock. Deutsche Bank’s price objective would indicate a potential upside of 1.95% from the stock’s previous close.
BTG plc (LON:BTG) traded up 1.58% during mid-day trading on Wednesday, hitting GBX 642.50. 618,931 shares of the company’s stock traded hands. BTG plc has a 1-year low of GBX 363.00 and a 1-year high of GBX 643.50. The stock has a 50-day moving average of GBX 579.9 and a 200-day moving average of GBX 574.3. The company’s market cap is £2.319 billion.
Other equities research analysts have also recently issued reports about the stock. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of BTG plc in a research note on Tuesday. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of BTG plc in a research note on Thursday, June 5th. They now have a GBX 525 ($8.94) price target on the stock. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of GBX 536.88 ($9.14).
BTG plc is an international specialist healthcare company. The Company is focused on three business areas: Specialty Pharmaceuticals, Interventional Medicine and Licensing & Biotechnology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.